LOS ANGELES, Sept. 20, 2016 -- Reed’s, Inc. (NYSE:REED), maker of the top selling craft sodas nationwide today announced that Reed’s and Virgil’s are now authorized and available in 1,135 CVS pharmacies throughout the country. CVS Health is headquartered in Woonsocket, RI and is the largest pharmacy health care provider in the U.S. operating 9,600 retail drug stores. CVS Health now offers Reed’s Extra and Premium, as well as Virgil’s Root Beer and Cream Sodas in a new specialty set that contains all natural and better-for-you beverages in stores that are being reset to offer more natural products across category.
Chris Reed, Founder and CEO of Reed’s commented, “When I started this company my goal was to dose up America with ginger, so it is totally fitting that our Reed’s and Virgil’s show up at CVS around the country. Many of our customers purchase Reed’s Ginger Brews for the health benefits of ginger, like improved digestion and to quell bouts of nausea. As the CVS consumer is demanding more healthy and natural beverage choices, Reeds and Virgil’s are positioned to be the anchor of the CVS craft and specialty beverage assortment. We are proud to collaborate with CVS as they innovatively reinvent today’s pharmacies by embracing the benefits of natural products like Reed’s and Virgil’s.”
About CVS Pharmacy
CVS Health (CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.
About Reed’s, Inc.
Reed’s, Inc. makes the top-selling sodas in the natural and specialty foods industry and are sold in over 15,000 natural and mainstream supermarkets nationwide. Reed’s products are sold through an additional estimated 40,000 accounts that include specialty gourmet, natural food stores, retail stores, convenience stores and restaurants nationwide and in select international markets. Reed’s has sold over 500 million bottles since inception in June 1989 and is considered the leader of the fast growing craft soda category. Its seven award-winning non-alcoholic Ginger Brews are unique in the beverage industry, being brewed, not manufactured and using fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks. The Company owns the top-selling root beer line in natural foods, the Virgil’s Root Beer product line, and a top-selling cola line in natural foods, the China Cola product line. In 2012, the Company launched its Reed’s Culture Club Kombucha line of organic live beverages. Other product lines include Reed’s Ginger Candies and Reed’s Ginger Ice Creams.
For more information about Reed’s, please visit the Company’s website at: http://www.reedsinc.com or call 800-99-REEDS.
Follow Reed’s on Twitter at http://twitter.com/reedsgingerbrew; Reed’s Facebook Fan Page at https://www.facebook.com/ReedsGingerBrew
SAFE HARBOR STATEMENT
Some portions of this press release, particularly those describing Reed’s goals and strategies, contain “forward-looking statements.” These forward-looking statements can generally be identified as such because the context of the statement will include words, such as “expects,” “should,” “believes,” “anticipates” or words of similar import. Similarly, statements that describe future plans, objectives or goals are also forward-looking statements. While Reed’s is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These risks and uncertainties include difficulty in marketing its products and services, maintaining and protecting brand recognition, the need for significant capital, dependence on third party distributors, dependence on third party brewers, increasing costs of fuel and freight, protection of intellectual property, competition and other factors, any of which could have an adverse effect on the business plans of Reed’s, its reputation in the industry or its expected financial return from operations and results of operations. In light of significant risks and uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by Reed’s that they will achieve such forward-looking statements. For further details and a discussion of these and other risks and uncertainties, please see our most recent reports on Form 10-K and Form 10-Q, as filed with the Securities and Exchange Commission, as they may be amended from time to time. Reed’s undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
CONTACT: Reed's, Inc. Investor Relations - Email: [email protected]


Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



